367501-41-5 Usage
General Description
5-Methanesulfonyl-1H-indole-2-carboxylic acid, also known as MSICA, is a synthetic chemical compound. It is a derivative of indole and contains a sulfonyl group and a carboxylic acid group. MSICA is used in the pharmaceutical industry as a building block in the synthesis of various drugs and pharmaceutical compounds. It is also used in the research and development of new drugs and chemical compounds. MSICA has potential therapeutic applications due to its unique structural properties and chemical reactivity. However, further studies and research are needed to fully understand its pharmacological and biological effects.
Check Digit Verification of cas no
The CAS Registry Mumber 367501-41-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,7,5,0 and 1 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 367501-41:
(8*3)+(7*6)+(6*7)+(5*5)+(4*0)+(3*1)+(2*4)+(1*1)=145
145 % 10 = 5
So 367501-41-5 is a valid CAS Registry Number.
367501-41-5Relevant articles and documents
ANTIBODY-DRUG CONJUGATES COMPRISING ANTI-B7-H3 ANTIBODIES
-
Page/Page column 149; 177-182, (2022/01/04)
The present disclosure relates to antibody-drug conjugates (ADCs) wherein one or more active agents are conjugated to an anti-B7-H3 antibody through a linker. The linker may comprise a unit that covalently links active agents to the antibody. The disclosure further relates to monoclonal antibodies and antigen binding fragments, variants, multimeric versions, or bispecifics thereof that specifically bind B7-H3, as well as methods of making and using these anti-B7-H3 antibodies and antigen-binding fragments thereof in a variety of therapeutic, diagnostic and prophylactic indications
Chemical compounds
-
, (2008/06/13)
The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
